| _version_ |
1797287808882180096
|
| collection |
DOAJ
|
| first_indexed |
2024-03-07T18:39:58Z
|
| format |
Article
|
| id |
doaj.art-00d919436ee24393bfc67bd188f55466
|
| institution |
Directory Open Access Journal
|
| issn |
2572-9241
|
| language |
English
|
| last_indexed |
2024-03-07T18:39:58Z
|
| publishDate |
2018-10-01
|
| publisher |
Wiley
|
| record_format |
Article
|
| series |
HemaSphere
|
| spelling |
doaj.art-00d919436ee24393bfc67bd188f554662024-03-02T03:56:07ZengWileyHemaSphere2572-92412018-10-0125310.1097/01.HS9.0000547977.84027.90201810003-00134P134 (0156) INDUCTION THERAPY WITH EVEROLIMUS IN COMBINATION WITH DHAP (DEXAMETHASONE, HIGH-DOSE ARAC, CISPLATINUM) IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: A RANDOMIZED, PLACEBO-CONTROLLED PHASE I/II TRIAL (HD-R3I)http://journals.lww.com/10.1097/01.HS9.0000547977.84027.90
|
| spellingShingle |
P134 (0156) INDUCTION THERAPY WITH EVEROLIMUS IN COMBINATION WITH DHAP (DEXAMETHASONE, HIGH-DOSE ARAC, CISPLATINUM) IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: A RANDOMIZED, PLACEBO-CONTROLLED PHASE I/II TRIAL (HD-R3I)
HemaSphere
|
| title |
P134 (0156) INDUCTION THERAPY WITH EVEROLIMUS IN COMBINATION WITH DHAP (DEXAMETHASONE, HIGH-DOSE ARAC, CISPLATINUM) IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: A RANDOMIZED, PLACEBO-CONTROLLED PHASE I/II TRIAL (HD-R3I)
|
| title_full |
P134 (0156) INDUCTION THERAPY WITH EVEROLIMUS IN COMBINATION WITH DHAP (DEXAMETHASONE, HIGH-DOSE ARAC, CISPLATINUM) IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: A RANDOMIZED, PLACEBO-CONTROLLED PHASE I/II TRIAL (HD-R3I)
|
| title_fullStr |
P134 (0156) INDUCTION THERAPY WITH EVEROLIMUS IN COMBINATION WITH DHAP (DEXAMETHASONE, HIGH-DOSE ARAC, CISPLATINUM) IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: A RANDOMIZED, PLACEBO-CONTROLLED PHASE I/II TRIAL (HD-R3I)
|
| title_full_unstemmed |
P134 (0156) INDUCTION THERAPY WITH EVEROLIMUS IN COMBINATION WITH DHAP (DEXAMETHASONE, HIGH-DOSE ARAC, CISPLATINUM) IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: A RANDOMIZED, PLACEBO-CONTROLLED PHASE I/II TRIAL (HD-R3I)
|
| title_short |
P134 (0156) INDUCTION THERAPY WITH EVEROLIMUS IN COMBINATION WITH DHAP (DEXAMETHASONE, HIGH-DOSE ARAC, CISPLATINUM) IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: A RANDOMIZED, PLACEBO-CONTROLLED PHASE I/II TRIAL (HD-R3I)
|
| title_sort |
p134 0156 induction therapy with everolimus in combination with dhap dexamethasone high dose arac cisplatinum in patients with relapsed or refractory classical hodgkin lymphoma a randomized placebo controlled phase i ii trial hd r3i
|
| url |
http://journals.lww.com/10.1097/01.HS9.0000547977.84027.90
|